These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Molecular genetics of septo-optic dysplasia. Dattani ML; Martinez-Barbera J; Thomas PQ; Brickman JM; Gupta R; Wales JK; Hindmarsh PC; Beddington RS; Robinson IC Horm Res; 2000; 53 Suppl 1():26-33. PubMed ID: 10895039 [TBL] [Abstract][Full Text] [Related]
9. From panhypopituitarism to combined pituitary deficiencies: do we need the anterior pituitary? Carrière C; Gleiberman A; Lin CR; Rosenfeld MG Rev Endocr Metab Disord; 2004 Mar; 5(1):5-13. PubMed ID: 14966385 [No Abstract] [Full Text] [Related]
10. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. McCabe MJ; Alatzoglou KS; Dattani MT Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):115-24. PubMed ID: 21396578 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Dattani MT; Martinez-Barbera JP; Thomas PQ; Brickman JM; Gupta R; Mårtensson IL; Toresson H; Fox M; Wales JK; Hindmarsh PC; Krauss S; Beddington RS; Robinson IC Nat Genet; 1998 Jun; 19(2):125-33. PubMed ID: 9620767 [TBL] [Abstract][Full Text] [Related]
20. The impact of R53C mutation on the three-dimensional structure, stability, and DNA-binding properties of the human Hesx-1 homeodomain. de la Mata I; Garcia JL; González C; Menéndez M; Cañada J; Jiménez-Barbero J; Asensio JL Chembiochem; 2002 Aug; 3(8):726-40. PubMed ID: 12203971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]